Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Turnaround Potential
261.6700 -7.48 (-2.78%)
NSE Sep 30, 2026 15:31 PM
Volume: 1.1M
 

261.67
-2.78%
ICICI Securities Limited
Formulation exports accounted for 40% (regulated markets:81%) of revenues while APIs contributed 8% with remaining coming from CRAMS Q3FY22 Results: Indoco reported revenue growth due to traction in domestic...
Indoco Remedies has gained 50.85% in the last 6 Months
More from Indoco Remedies Ltd.
Recommended